Screener
Tandem Diabetes Care
TNDMTandem Diabetes Care is a global medical technology company focused on the design, development, and commercialization of advanced insulin delivery systems.
Earnings
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$266.1M
EPS estimate-$0.26
Valuation & ratios
Segments
By product
Competitors
By market cap
By revenue growth
By net margin
Profile
Tandem Diabetes Care is a global medical technology company focused on the design, development, and commercialization of advanced insulin delivery systems. The company provides intelligent pump platforms and integrated software solutions aimed at reducing the daily burden of diabetes management for patients worldwide.
Competitive position
A leading provider of automated insulin delivery systems known for advanced hybrid closed-loop technology and user-centric design.
GeographiesUnited States, International
Customer segmentsType 1 diabetes patients, Insulin-intensive Type 2 diabetes patients
Business modelMedical device manufacturing, Razor-and-blade (hardware and recurring consumables)
SuppliersElectronic component manufacturers, Specialized medical-grade plastics suppliers, Software developers
CustomersDurable medical equipment (DME) distributors, Pharmacies, Direct-to-patient sales
CountryUnited States of America
Listed2013
Employees2.4K
CEOJohn F. Sheridan
SectorHealthcare
IndustryMedical - Devices
Websitetandemdiabetes.com
FilingsSEC EDGAR
FAQ
- What is Tandem Diabetes Care's market cap?
- Tandem Diabetes Care (TNDM) has a market capitalization of $1.2B and trades on NASDAQ.
- What is Tandem Diabetes Care's revenue and profitability?
- Tandem Diabetes Care generated $1.0B in trailing twelve-month revenue with a net loss of $63.3M, representing a net margin of -6.1%. Gross margin stands at 56.0%, with free cash flow of -$70.8M. The latest reported period is Q2 2026.
- Who are Tandem Diabetes Care's competitors?
- Tandem Diabetes Care's key competitors include Insulet, Medtronic, Abbott Laboratories, and others. These companies compete in similar markets and product categories.
- Who does Tandem Diabetes Care partner with?
- Tandem Diabetes Care's notable partners include Dexcom, Abbott.
- Where is Tandem Diabetes Care headquartered?
- Tandem Diabetes Care is headquartered in United States of America and employs approximately 2,400 people. It has been publicly traded since 2013.
